The Chinese Coronavirus vaccine may be ready for public use as early as in November an official with the China Centre for Disease Control and Prevention (CDC) said, reports NDTV.
Till now, China has developed four COVID-19 vaccines and all are in their final stage of clinical trials. Three of the vaccines have already been offered to essential workers under an emergency use programme launched in July, the report stated.
NDTV quoted CDC chief and bio safety expert Guizhen Wu as saying that Phase 3 clinical trials were proceeding smoothly and the vaccines could be ready for the general public in November or December.
Without specifying which vaccine, Guizhen Wu said she has experienced no abnormal symptoms in recent months after taking an experimental vaccine herself in April.
Amongst the four vaccines, three of them are being developed by a unit of state pharmaceutical giant China National Pharmaceutical Group (Sinopharm) and US-listed Sinovac Biotech under the state's emergency use programme. Fourth COVID-19 vaccine being developed by CanSino Biologics was approved for use by the Chinese military in June, the report said.
Vaccine could be ready for public use by the end of this year after the conclusion of Phase 3 trials, says Sinopharm.
global vaccine inventors are racing to develop an effective vaccine against the deadly COVID-19 infection which has killed more than 925,000 people around the globe. Leading Western vaccine makers pledged earlier this month to uphold scientific study standards and reject any political pressure to rush the process.